Suchergebnisse - "Guzauskas, Gregory F"

PubPharm (4)

1

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma : a cost-effectiveness study

enthalten in: Journal of medical economics | 2019

von Guzauskas, G. | Pollom, E. | Stieber, V. | +2

2

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States

enthalten in: Leukemia & lymphoma | 2019

von Guzauskas, G. | Masaquel, A. | Thuresson, P. | +2

3

Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US

enthalten in: Journal of medical economics | 2018

von Guzauskas, G. | Masaquel, A. | Reyes, C. | +3

4

Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke : current evidence

enthalten in: Stroke | 2014

von Boudreau, D. | Guzauskas, G. | Chen, E. | +4

1
[1]